NewsBenzingaAmphastar Pharma: BPA ajustado del T3 de 1,14 dólares supera la estimación de 0,86 dólares; ventas de 207,608 millones de dólares superan la estimación de 197,852 millones de dólares Amphastar Pharma: BPA ajustado del T3 de 1,14 dólares supera la estimación de 0,86 dólares; ventas de 207,608 millones de dólares superan la estimación de 197,852 millones de dólares Benzinga 2026.11.05 21:12 (GMT+0) Open on Benzinga Other news TD Cowen Maintains Buy Rating on Sharplink With $13 Price Target Tencent's Q3 Revenue Up 8% YoY to RMB 207.3 Billion Realty Income vs. Agree Realty: Which REIT Wins on Dividends and Growth? Salesforce Issues Security Advisory On Third-Party Optimizely Script Incident Affecting Certain Salesforce-Branded Sites; Optimizely Scripts Being Confirmed Disabled FBI Reissues Warning About AI-Powered Cyberattacks on Businesses as Crypto Bettors Dismiss AI Link to FAA Outage Is Wall Street Bullish or Bearish on Solventum Stock?
Salesforce Issues Security Advisory On Third-Party Optimizely Script Incident Affecting Certain Salesforce-Branded Sites; Optimizely Scripts Being Confirmed Disabled
FBI Reissues Warning About AI-Powered Cyberattacks on Businesses as Crypto Bettors Dismiss AI Link to FAA Outage